| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.995 | 0.002 | 0.995 | Epidermal growth factor antagonist | 0.581 0.004 CID_6570 | ||
| 0.937 | 0.004 | 0.937 | Growth factor antagonist | 0.244 0.036 CID_6570 | ||
| 0.907 | 0.002 | 0.907 | Bruton tyrosine kinase inhibitor | 0.058 0.037 CID_13586 0.237 0.005 CID_6570 | ||
| 0.784 | 0.003 | 0.784 | ErbB-4 antagonist | 0.127 0.028 CID_6570 | ||
| 0.777 | 0.004 | 0.777 | Antimitotic | |||
| 0.768 | 0.004 | 0.768 | Epidermal growth factor receptor kinase inhibitor | 0.433 0.005 CID_6570 | ||
| 0.761 | 0.021 | 0.77 | Apoptosis agonist | 0.77 0.02 CID_13586 0.666 0.036 CID_6570 | CID_13586 | |
| 0.723 | 0.003 | 0.723 | GABA C receptor rho-3 antagonist | 0.485 0.03 CID_13586 0.666 0.004 CID_6570 | ||
| 0.732 | 0.025 | 0.732 | Antiinflammatory | 0.464 0.104 CID_6570 | ||
| 0.658 | 0.007 | 0.721 | Immunosuppressant | 0.318 0.104 CID_13586 0.721 0.005 CID_6570 | CID_6570 | |
| 0.668 | 0.028 | 0.809 | Caspase 9 stimulant | 0.674 0.027 CID_13586 0.809 0.01 CID_6570 | CID_6570 | |
| 0.648 | 0.01 | 0.726 | 5 Hydroxytryptamine release stimulant | 0.726 0.005 CID_13586 0.605 0.014 CID_6570 | CID_13586 | |
| 0.544 | 0.005 | 0.544 | NOS3 expression enhancer | 0.166 0.059 CID_6570 | ||
| 0.53 | 0.005 | 0.53 | Alpha-N-acetylglucosaminidase inhibitor | 0.409 0.008 CID_13586 0.393 0.009 CID_6570 | ||
| 0.53 | 0.007 | 0.53 | Tubulin antagonist | |||
| 0.528 | 0.007 | 0.528 | Sigma receptor agonist | 0.132 0.1 CID_6570 | ||
| 0.531 | 0.019 | 0.531 | Immunomodulator | |||
| 0.514 | 0.004 | 0.514 | GABA C receptor agonist | 0.157 0.031 CID_13586 0.306 0.009 CID_6570 | ||
| 0.475 | 0.01 | 0.475 | ErbB-1 antagonist | 0.222 0.069 CID_6570 | ||
| 0.468 | 0.005 | 0.468 | 5 Hydroxytryptamine uptake stimulant | 0.308 0.041 CID_13586 0.399 0.014 CID_6570 | ||
| 0.459 | 0.005 | 0.459 | Cell adhesion inhibitor | |||
| 0.489 | 0.039 | 0.489 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.354 0.146 CID_13586 0.413 0.09 CID_6570 | ||
| 0.468 | 0.025 | 0.815 | Caspase 3 stimulant | 0.22 0.143 CID_13586 0.815 0.004 CID_6570 | CID_6570 | |
| 0.472 | 0.037 | 0.472 | Aldehyde oxidase inhibitor | 0.168 0.124 CID_13586 0.411 0.045 CID_6570 | ||
| 0.47 | 0.037 | 0.47 | Cholesterol antagonist | 0.337 0.07 CID_13586 0.388 0.052 CID_6570 | ||
| 0.451 | 0.019 | 0.451 | Superoxide dismutase inhibitor | 0.229 0.089 CID_13586 0.415 0.024 CID_6570 | ||
| 0.435 | 0.004 | 0.435 | Tyrosine-protein kinase EMT inhibitor | |||
| 0.434 | 0.003 | 0.434 | Ferrochelatase inhibitor | 0.326 0.005 CID_13586 0.35 0.005 CID_6570 | ||
| 0.421 | 0.003 | 0.421 | GABA C receptor rho-2 antagonist | 0.204 0.027 CID_13586 0.318 0.005 CID_6570 | ||
| 0.421 | 0.003 | 0.421 | GABA C receptor antagonist | 0.177 0.019 CID_13586 0.276 0.005 CID_6570 | ||
| 0.422 | 0.018 | 0.422 | Peroxidase inhibitor | 0.221 0.054 CID_13586 0.283 0.041 CID_6570 | ||
| 0.414 | 0.015 | 0.444 | Anesthetic general | 0.277 0.04 CID_13586 0.444 0.012 CID_6570 | CID_6570 | |
| 0.392 | 0.004 | 0.457 | Succinate dehydrogenase inhibitor | 0.286 0.013 CID_13586 0.457 0.003 CID_6570 | CID_6570 | |
| 0.403 | 0.024 | 0.412 | Calcium channel activator | 0.412 0.02 CID_13586 0.334 0.061 CID_6570 | CID_13586 | |
| 0.382 | 0.01 | 0.382 | Tyrosine 3 hydroxylase inhibitor | 0.245 0.073 CID_13586 0.327 0.022 CID_6570 | ||
| 0.376 | 0.005 | 0.376 | Janus tyrosine kinase 3 inhibitor | |||
| 0.373 | 0.003 | 0.373 | ErbB-3 antagonist | 0.128 0.026 CID_6570 | ||
| 0.426 | 0.062 | 0.426 | Histamine release inhibitor | 0.283 0.133 CID_13586 0.307 0.12 CID_6570 | ||
| 0.424 | 0.064 | 0.424 | 5 Hydroxytryptamine release inhibitor | 0.402 0.077 CID_13586 0.349 0.116 CID_6570 | ||
| 0.337 | 0.003 | 0.337 | GABA C receptor rho-1 antagonist | 0.145 0.024 CID_13586 0.241 0.005 CID_6570 | ||
| 0.389 | 0.059 | 0.429 | Vasodilator, peripheral | 0.409 0.052 CID_13586 0.429 0.047 CID_6570 | CID_6570 | |
| 0.333 | 0.005 | 0.466 | Porphobilinogen synthase inhibitor | 0.169 0.017 CID_13586 0.466 0.004 CID_6570 | CID_6570 | |
| 0.34 | 0.012 | 0.34 | 5 Hydroxytryptamine 1E antagonist | 0.195 0.137 CID_13586 0.283 0.042 CID_6570 | ||
| 0.332 | 0.004 | 0.332 | Triose-phosphate isomerase inhibitor | 0.231 0.008 CID_13586 0.289 0.005 CID_6570 | ||
| 0.324 | 0.005 | 0.349 | Adenylate kinase inhibitor | 0.231 0.011 CID_13586 0.349 0.005 CID_6570 | CID_6570 | |
| 0.35 | 0.032 | 0.411 | Nitric oxide antagonist | 0.233 0.057 CID_13586 0.411 0.024 CID_6570 | CID_6570 | |
| 0.392 | 0.08 | 0.399 | Antibacterial | 0.399 0.077 CID_13586 0.294 0.14 CID_6570 | CID_13586 | |
| 0.303 | 0.003 | 0.303 | Fibroblast growth factor 4 antagonist | 0.086 0.014 CID_6570 | ||
| 0.339 | 0.038 | 0.339 | Insulysin inhibitor | 0.193 0.167 CID_13586 0.33 0.042 CID_6570 | ||
| 0.314 | 0.02 | 0.314 | Peptidyltransferase inhibitor | 0.211 0.086 CID_13586 0.213 0.083 CID_6570 | ||
| 0.295 | 0.004 | 0.33 | MAP3K7 inhibitor | 0.33 0.004 CID_6570 | CID_6570 | |
| 0.289 | 0.007 | 0.289 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.223 0.013 CID_13586 0.255 0.009 CID_6570 | ||
| 0.307 | 0.03 | 0.307 | RNA-directed DNA polymerase inhibitor | 0.274 0.038 CID_13586 0.228 0.066 CID_6570 | ||
| 0.294 | 0.019 | 0.294 | Phospholipase C inhibitor | 0.198 0.045 CID_13586 0.217 0.035 CID_6570 | ||
| 0.35 | 0.077 | 0.462 | Transcription factor NF kappa B inhibitor | 0.283 0.104 CID_13586 0.462 0.051 CID_6570 | CID_6570 | |
| 0.302 | 0.032 | 0.302 | Gastrin inhibitor | 0.202 0.146 CID_13586 0.273 0.055 CID_6570 | ||
| 0.272 | 0.009 | 0.272 | 5 Hydroxytryptamine 3E antagonist | 0.22 0.037 CID_13586 0.227 0.03 CID_6570 | ||
| 0.298 | 0.044 | 0.343 | DNA synthesis inhibitor | 0.343 0.032 CID_13586 0.26 0.06 CID_6570 | CID_13586 | |
| 0.322 | 0.071 | 0.323 | Vasodilator, coronary | 0.323 0.07 CID_13586 0.243 0.142 CID_6570 | CID_13586 | |
| 0.254 | 0.007 | 0.254 | Phosphofructokinase-1 inhibitor | 0.203 0.011 CID_13586 0.21 0.01 CID_6570 | ||
| 0.259 | 0.013 | 0.311 | UDP-glucose 4-epimerase inhibitor | 0.202 0.018 CID_13586 0.311 0.01 CID_6570 | CID_6570 | |
| 0.251 | 0.004 | 0.251 | Adenylate cyclase stimulant | 0.216 0.008 CID_13586 0.216 0.008 CID_6570 | ||
| 0.249 | 0.005 | 0.249 | Electrolyte absorption antagonist | 0.114 0.042 CID_13586 0.166 0.014 CID_6570 | ||
| 0.245 | 0.004 | 0.245 | Biliverdin reductase inhibitor | 0.234 0.004 CID_13586 0.156 0.009 CID_6570 | ||
| 0.265 | 0.026 | 0.265 | Cytidine deaminase inhibitor | 0.211 0.042 CID_13586 0.251 0.029 CID_6570 | ||
| 0.26 | 0.026 | 0.26 | Nitric-oxide synthase stimulant | 0.223 0.057 CID_13586 0.219 0.061 CID_6570 | ||
| 0.239 | 0.008 | 0.268 | Glutamate dehydrogenase inhibitor | 0.133 0.019 CID_13586 0.268 0.006 CID_6570 | CID_6570 | |
| 0.236 | 0.005 | 0.236 | Vanilloid agonist | 0.122 0.018 CID_6570 | ||
| 0.294 | 0.066 | 0.294 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.261 0.075 CID_6570 | ||
| 0.239 | 0.011 | 0.24 | Microtubule formation inhibitor | 0.24 0.011 CID_13586 0.179 0.025 CID_6570 | CID_13586 | |
| 0.309 | 0.082 | 0.309 | Antithrombotic | 0.257 0.121 CID_13586 0.299 0.088 CID_6570 | ||
| 0.229 | 0.007 | 0.3 | TRPA1 agonist | 0.106 0.078 CID_13586 0.3 0.005 CID_6570 | CID_6570 | |
| 0.262 | 0.04 | 0.431 | Growth hormone agonist | 0.431 0.012 CID_13586 0.123 0.116 CID_6570 | CID_13586 | |
| 0.238 | 0.017 | 0.238 | ATPase inhibitor | 0.187 0.049 CID_13586 0.198 0.039 CID_6570 | ||
| 0.25 | 0.028 | 0.25 | Interferon gamma antagonist | 0.177 0.052 CID_13586 0.189 0.045 CID_6570 | ||
| 0.309 | 0.088 | 0.309 | Angiogenesis inhibitor | |||
| 0.28 | 0.059 | 0.28 | Interleukin agonist | 0.195 0.125 CID_13586 0.205 0.116 CID_6570 | ||
| 0.231 | 0.011 | 0.235 | Arachidonic acid antagonist | 0.194 0.039 CID_13586 0.235 0.01 CID_6570 | CID_6570 | |
| 0.228 | 0.01 | 0.228 | CF transmembrane conductance regulator agonist | 0.187 0.03 CID_13586 0.18 0.036 CID_6570 | ||
| 0.243 | 0.03 | 0.281 | Melanin inhibitor | 0.171 0.059 CID_13586 0.281 0.024 CID_6570 | CID_6570 | |
| 0.214 | 0.004 | 0.214 | Acyl-CoA dehydrogenase inhibitor | 0.148 0.009 CID_13586 0.189 0.006 CID_6570 | ||
| 0.216 | 0.009 | 0.216 | HIV-1 integrase (Overall Integration) inhibitor | 0.181 0.016 CID_6570 | ||
| 0.273 | 0.068 | 0.273 | Transcription factor STAT3 inhibitor | 0.212 0.119 CID_6570 | ||
| 0.227 | 0.022 | 0.274 | Aldehyde dehydrogenase inhibitor | 0.124 0.067 CID_13586 0.274 0.014 CID_6570 | CID_6570 | |
| 0.237 | 0.032 | 0.237 | Amylase inhibitor | 0.15 0.064 CID_13586 0.161 0.059 CID_6570 | ||
| 0.288 | 0.087 | 0.288 | 12-Lipoxygenase inhibitor | 0.28 0.091 CID_6570 | ||
| 0.207 | 0.006 | 0.207 | Alcohol oxidase inhibitor | 0.07 0.029 CID_13586 0.138 0.011 CID_6570 | ||
| 0.208 | 0.008 | 0.208 | Prolactin inhibitor | 0.093 0.063 CID_13586 0.156 0.02 CID_6570 | ||
| 0.206 | 0.006 | 0.206 | Glutamate decarboxylase inhibitor | 0.094 0.033 CID_13586 0.184 0.008 CID_6570 | ||
| 0.218 | 0.02 | 0.218 | Cystathionine beta-synthase inhibitor | 0.117 0.06 CID_13586 0.142 0.044 CID_6570 | ||
| 0.202 | 0.009 | 0.202 | Transcription factor NF kappa B stimulant | 0.149 0.016 CID_6570 | ||
| 0.257 | 0.064 | 0.257 | Hypolipemic | |||
| 0.229 | 0.037 | 0.229 | 3C-like protease (Human coronavirus) inhibitor | 0.216 0.043 CID_13586 0.196 0.054 CID_6570 | ||
| 0.201 | 0.01 | 0.201 | NADH dehydrogenase inhibitor | 0.166 0.014 CID_13586 0.133 0.023 CID_6570 | ||
| 0.197 | 0.007 | 0.259 | Phenylalanine 4-hydroxylase inhibitor | 0.259 0.005 CID_13586 0.118 0.019 CID_6570 | CID_13586 | |
| 0.193 | 0.004 | 0.193 | GABA aminotransferase inhibitor | 0.079 0.048 CID_13586 0.133 0.011 CID_6570 | ||
| 0.264 | 0.077 | 0.264 | Transcription factor STAT inhibitor | 0.184 0.161 CID_6570 | ||
| 0.235 | 0.048 | 0.244 | Neurotrophic factor enhancer | 0.162 0.12 CID_13586 0.244 0.042 CID_6570 | CID_6570 | |
| 0.191 | 0.004 | 0.191 | Ca2+-transporting ATPase inhibitor | 0.166 0.017 CID_13586 0.174 0.01 CID_6570 | ||
| 0.273 | 0.087 | 0.273 | Immunostimulant | 0.223 0.108 CID_13586 0.238 0.101 CID_6570 | ||
| 0.249 | 0.064 | 0.249 | Cyclic AMP phosphodiesterase inhibitor | 0.164 0.131 CID_13586 0.238 0.07 CID_6570 | ||
| 0.236 | 0.053 | 0.236 | DNA methyltransferase I inhibitor | 0.147 0.107 CID_13586 0.226 0.057 CID_6570 | ||
| 0.19 | 0.007 | 0.19 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.155 0.008 CID_13586 0.117 0.011 CID_6570 | ||
| 0.191 | 0.008 | 0.191 | Heat shock protein 70 antagonist | 0.142 0.066 CID_13586 0.158 0.031 CID_6570 | ||
| 0.216 | 0.036 | 0.216 | Protein kinase stimulant | 0.197 0.043 CID_13586 0.167 0.057 CID_6570 | ||
| 0.188 | 0.009 | 0.188 | CYP2A6 inhibitor | 0.093 0.04 CID_13586 0.187 0.009 CID_6570 | ||
| 0.192 | 0.014 | 0.192 | Photosensitizer | 0.175 0.02 CID_13586 0.176 0.019 CID_6570 | ||
| 0.229 | 0.053 | 0.229 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.191 0.08 CID_13586 0.201 0.071 CID_6570 | ||
| 0.18 | 0.009 | 0.18 | Toll-Like receptor 4 antagonist | 0.093 0.082 CID_13586 0.135 0.03 CID_6570 | ||
| 0.2 | 0.03 | 0.202 | Cell wall synthesis inhibitor | 0.202 0.029 CID_13586 0.157 0.059 CID_6570 | CID_13586 | |
| 0.183 | 0.014 | 0.183 | Creatine kinase inhibitor | 0.105 0.054 CID_13586 0.142 0.028 CID_6570 | ||
| 0.195 | 0.026 | 0.195 | Toll-Like receptor 2 antagonist | 0.12 0.077 CID_13586 0.158 0.047 CID_6570 | ||
| 0.184 | 0.015 | 0.184 | Papain-like protease (SARS coronavirus) inhibitor | 0.142 0.042 CID_6570 | ||
| 0.174 | 0.008 | 0.174 | Glutathione S-transferase inhibitor | 0.105 0.033 CID_13586 0.169 0.009 CID_6570 | ||
| 0.221 | 0.055 | 0.221 | I kappa B kinase epsilon inhibitor | |||
| 0.226 | 0.063 | 0.226 | DNA methylase inhibitor | 0.142 0.124 CID_13586 0.206 0.075 CID_6570 | ||
| 0.165 | 0.003 | 0.165 | Exportin-1 inhibitor | 0.116 0.005 CID_13586 0.144 0.004 CID_6570 | ||
| 0.218 | 0.057 | 0.218 | Insulin sensitizer | 0.169 0.109 CID_6570 | ||
| 0.247 | 0.086 | 0.405 | Antioxidant | 0.405 0.034 CID_6570 | CID_6570 | |
| 0.179 | 0.019 | 0.179 | Vanilloid 1 agonist | 0.131 0.065 CID_13586 0.175 0.021 CID_6570 | ||
| 0.193 | 0.034 | 0.193 | Anesthetic local | 0.094 0.088 CID_13586 0.164 0.043 CID_6570 | ||
| 0.186 | 0.029 | 0.198 | Adenylate cyclase inhibitor | 0.198 0.026 CID_13586 0.139 0.053 CID_6570 | CID_13586 | |
| 0.187 | 0.03 | 0.187 | Cholesterol synthesis inhibitor | 0.128 0.058 CID_13586 0.157 0.041 CID_6570 | ||
| 0.161 | 0.005 | 0.161 | Glycine receptor agonist | 0.112 0.015 CID_13586 0.119 0.013 CID_6570 | ||
| 0.164 | 0.01 | 0.164 | Beta tubulin antagonist | |||
| 0.164 | 0.012 | 0.167 | Anabolic | 0.142 0.023 CID_13586 0.167 0.011 CID_6570 | CID_6570 | |
| 0.177 | 0.025 | 0.177 | Xanthine oxidase inhibitor | 0.089 0.072 CID_6570 | ||
| 0.16 | 0.01 | 0.16 | Carbamoyl phosphate synthetase inhibitor | 0.124 0.015 CID_13586 0.131 0.014 CID_6570 | ||
| 0.22 | 0.071 | 0.222 | Pyruvate kinase inhibitor | 0.222 0.07 CID_6570 | CID_6570 | |
| 0.155 | 0.006 | 0.155 | Glycine receptor antagonist | 0.107 0.027 CID_13586 0.123 0.017 CID_6570 | ||
| 0.155 | 0.009 | 0.155 | Ornithine carbamoyltransferase inhibitor | 0.074 0.024 CID_13586 0.1 0.016 CID_6570 | ||
| 0.176 | 0.03 | 0.176 | Cyclooxygenase 3 inhibitor | 0.169 0.034 CID_13586 0.147 0.051 CID_6570 | ||
| 0.155 | 0.01 | 0.168 | Lanosterol 14 alpha demethylase inhibitor | 0.168 0.007 CID_13586 0.151 0.011 CID_6570 | CID_13586 | |
| 0.149 | 0.004 | 0.149 | Aconitate hydratase inhibitor | 0.061 0.025 CID_13586 0.115 0.006 CID_6570 | ||
| 0.184 | 0.04 | 0.184 | Mannose-6-phosphate isomerase inhibitor | 0.153 0.062 CID_13586 0.119 0.103 CID_6570 | ||
| 0.17 | 0.026 | 0.17 | 5 Hydroxytryptamine 3A agonist | |||
| 0.178 | 0.036 | 0.178 | MAP kinase 3 inhibitor | 0.129 0.109 CID_6570 | ||
| 0.205 | 0.062 | 0.205 | Histone acetyltransferase inhibitor | 0.195 0.076 CID_6570 | ||
| 0.164 | 0.025 | 0.164 | Mucolytic | 0.159 0.028 CID_13586 0.148 0.034 CID_6570 | ||
| 0.195 | 0.057 | 0.195 | Tumour necrosis factor antagonist | |||
| 0.153 | 0.02 | 0.159 | DOPA decarboxylase inhibitor | 0.159 0.017 CID_6570 | CID_6570 | |
| 0.228 | 0.094 | 0.289 | DNA damaging | 0.289 0.062 CID_13586 | CID_13586 | |
| 0.148 | 0.018 | 0.148 | Acetylcholine release stimulant | 0.101 0.086 CID_13586 0.128 0.037 CID_6570 | ||
| 0.179 | 0.051 | 0.179 | Neurotensin receptor agonist | 0.143 0.12 CID_13586 0.148 0.107 CID_6570 | ||
| 0.275 | 0.146 | 0.275 | 15-Lipoxygenase inhibitor | 0.211 0.201 CID_6570 | ||
| 0.164 | 0.037 | 0.164 | Cathepsin H inhibitor | 0.116 0.08 CID_13586 0.153 0.044 CID_6570 | ||
| 0.132 | 0.006 | 0.132 | 5 Hydroxytryptamine 3 agonist | 0.073 0.033 CID_6570 | ||
| 0.174 | 0.052 | 0.236 | Thiol protease inhibitor | 0.236 0.029 CID_6570 | CID_6570 | |
| 0.143 | 0.021 | 0.16 | Histidine decarboxylase inhibitor | 0.16 0.018 CID_6570 | CID_6570 | |
| 0.129 | 0.008 | 0.129 | Protein 50S ribosomal subunit inhibitor | |||
| 0.125 | 0.005 | 0.125 | Squalene synthetase inhibitor | 0.066 0.01 CID_13586 0.099 0.006 CID_6570 | ||
| 0.122 | 0.003 | 0.122 | Microtubule stabilization | 0.052 0.025 CID_13586 | ||
| 0.13 | 0.013 | 0.13 | Nicotinic alpha4beta2 receptor antagonist | 0.074 0.057 CID_13586 0.084 0.046 CID_6570 | ||
| 0.153 | 0.037 | 0.153 | Sphingosine 1-phosphate receptor 2 antagonist | 0.131 0.071 CID_6570 | ||
| 0.153 | 0.036 | 0.153 | Aminopeptidase B inhibitor | 0.14 0.042 CID_6570 | ||
| 0.157 | 0.041 | 0.157 | Pregnane X receptor agonist | 0.133 0.092 CID_13586 0.136 0.084 CID_6570 | ||
| 0.119 | 0.003 | 0.119 | Adenylate cyclase 1 inhibitor | 0.102 0.004 CID_13586 0.098 0.004 CID_6570 | ||
| 0.158 | 0.043 | 0.158 | Interleukin 4 antagonist | |||
| 0.143 | 0.028 | 0.182 | Catalase inhibitor | 0.063 0.062 CID_13586 0.182 0.019 CID_6570 | CID_6570 | |
| 0.12 | 0.006 | 0.12 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.087 0.025 CID_13586 0.092 0.021 CID_6570 | ||
| 0.194 | 0.083 | 0.194 | Psychostimulant | 0.188 0.087 CID_13586 | ||
| 0.13 | 0.019 | 0.13 | Ornithine decarboxylase inhibitor | 0.109 0.035 CID_13586 0.127 0.021 CID_6570 | ||
| 0.145 | 0.037 | 0.145 | Expectorant | 0.141 0.039 CID_13586 0.12 0.05 CID_6570 | ||
| 0.122 | 0.014 | 0.122 | Granulocyte macrophage colony stimulating factor agonist | 0.083 0.068 CID_13586 0.106 0.028 CID_6570 | ||
| 0.116 | 0.008 | 0.116 | Vanilloid 4 agonist | 0.103 0.015 CID_13586 0.095 0.02 CID_6570 | ||
| 0.113 | 0.005 | 0.113 | MAP kinase kinase 7 inhibitor | 0.078 0.053 CID_13586 0.092 0.021 CID_6570 | ||
| 0.183 | 0.075 | 0.183 | Tyrosine kinase inhibitor | |||
| 0.156 | 0.051 | 0.156 | NADPH oxidase inhibitor | |||
| 0.144 | 0.039 | 0.151 | Sphingosine 1-phosphate receptor 4 antagonist | 0.151 0.032 CID_6570 | CID_6570 | |
| 0.109 | 0.004 | 0.109 | Glucose-6-phosphate isomerase inhibitor | 0.106 0.004 CID_13586 0.094 0.006 CID_6570 | ||
| 0.109 | 0.004 | 0.12 | Dihydroorotate oxidase inhibitor | 0.058 0.033 CID_13586 0.12 0.004 CID_6570 | CID_6570 | |
| 0.12 | 0.015 | 0.161 | Argininosuccinate synthase inhibitor | 0.069 0.03 CID_13586 0.161 0.01 CID_6570 | CID_6570 | |
| 0.15 | 0.047 | 0.198 | Proteasome inhibitor | 0.112 0.072 CID_13586 0.198 0.026 CID_6570 | CID_6570 | |
| 0.155 | 0.054 | 0.155 | Sphingosine 1-phosphate receptor 5 antagonist | 0.129 0.101 CID_6570 | ||
| 0.123 | 0.022 | 0.123 | Phosphodiesterase 6D inhibitor | 0.101 0.051 CID_13586 0.109 0.037 CID_6570 | ||
| 0.123 | 0.023 | 0.137 | Inducible nitric-oxide synthase inhibitor | 0.137 0.019 CID_6570 | CID_6570 | |
| 0.224 | 0.125 | 0.224 | Hypoxia-inducible factor 1 alpha inhibitor | 0.194 0.159 CID_13586 0.184 0.172 CID_6570 | ||
| 0.178 | 0.081 | 0.231 | Hepatoprotectant | 0.155 0.105 CID_13586 0.231 0.049 CID_6570 | CID_6570 | |
| 0.145 | 0.049 | 0.22 | Monophenol monooxygenase inhibitor | 0.088 0.085 CID_13586 0.22 0.029 CID_6570 | CID_6570 | |
| 0.099 | 0.003 | 0.099 | Kainate receptor agonist | 0.058 0.008 CID_13586 0.075 0.004 CID_6570 | ||
| 0.105 | 0.009 | 0.105 | Glutamate (mGluR6) antagonist | 0.077 0.027 CID_13586 0.085 0.02 CID_6570 | ||
| 0.114 | 0.019 | 0.114 | Sphingosine 1-phosphate receptor 4 agonist | 0.069 0.046 CID_13586 0.062 0.052 CID_6570 | ||
| 0.109 | 0.014 | 0.109 | CC chemokine 5 receptor agonist | 0.086 0.045 CID_6570 | ||
| 0.099 | 0.004 | 0.099 | Dopamine beta hydroxylase inhibitor | 0.074 0.007 CID_13586 0.062 0.013 CID_6570 | ||
| 0.11 | 0.015 | 0.122 | TRPA1 antagonist | 0.122 0.014 CID_6570 | CID_6570 | |
| 0.115 | 0.02 | 0.115 | Na+ K+ transporting ATPase inhibitor | 0.112 0.022 CID_13586 0.102 0.03 CID_6570 | ||
| 0.116 | 0.021 | 0.116 | Aminopeptidase I inhibitor | 0.067 0.057 CID_13586 0.107 0.024 CID_6570 | ||
| 0.161 | 0.067 | 0.161 | Hexokinase inhibitor | 0.141 0.09 CID_6570 | ||
| 0.207 | 0.114 | 0.207 | Spasmolytic | 0.2 0.119 CID_13586 0.168 0.147 CID_6570 | ||
| 0.097 | 0.004 | 0.097 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.037 0.025 CID_13586 0.048 0.013 CID_6570 | ||
| 0.097 | 0.005 | 0.097 | Lysophosphatidic acid 3 receptor antagonist | 0.055 0.028 CID_13586 0.08 0.009 CID_6570 | ||
| 0.107 | 0.016 | 0.107 | Acetylcholine muscarinic agonist | 0.051 0.042 CID_13586 | ||
| 0.15 | 0.06 | 0.15 | Alkaline phosphatase inhibitor | 0.108 0.103 CID_6570 | ||
| 0.178 | 0.089 | 0.178 | Non-steroidal antiinflammatory agent | 0.171 0.095 CID_6570 | ||
| 0.124 | 0.035 | 0.124 | Nitric-oxide synthase inhibitor | 0.112 0.044 CID_6570 | ||
| 0.101 | 0.014 | 0.101 | Phospholipase D inhibitor | 0.076 0.041 CID_13586 0.072 0.05 CID_6570 | ||
| 0.129 | 0.041 | 0.129 | Carbonic anhydrase XV inhibitor | 0.102 0.064 CID_6570 | ||
| 0.114 | 0.026 | 0.114 | Glutamate release inhibitor | 0.087 0.07 CID_13586 0.103 0.039 CID_6570 | ||
| 0.096 | 0.009 | 0.111 | Potassium channel Kv1.3 blocker | 0.111 0.007 CID_13586 0.064 0.018 CID_6570 | CID_13586 | |
| 0.121 | 0.034 | 0.121 | MAP kinase kinase 1 inhibitor | |||
| 0.132 | 0.046 | 0.132 | Falcipain 3 inhibitor | 0.109 0.062 CID_6570 | ||
| 0.134 | 0.048 | 0.134 | Alpha 2b adrenoreceptor antagonist | 0.122 0.057 CID_13586 | ||
| 0.12 | 0.035 | 0.12 | Calcium antagonist | 0.11 0.041 CID_13586 0.117 0.037 CID_6570 | ||
| 0.091 | 0.006 | 0.107 | Fumarate hydratase inhibitor | 0.044 0.016 CID_13586 0.107 0.005 CID_6570 | CID_6570 | |
| 0.121 | 0.036 | 0.121 | Acetylcholine agonist | |||
| 0.154 | 0.07 | 0.154 | Acetylcholine M1 receptor antagonist | 0.139 0.086 CID_6570 | ||
| 0.088 | 0.005 | 0.088 | Lysophosphatidic acid 2 receptor antagonist | 0.043 0.011 CID_6570 | ||
| 0.108 | 0.026 | 0.108 | Keratolytic | 0.07 0.064 CID_13586 0.094 0.035 CID_6570 | ||
| 0.122 | 0.04 | 0.122 | Sphingomyelinase inhibitor | 0.084 0.08 CID_6570 | ||
| 0.087 | 0.006 | 0.087 | Ryanodine receptor antagonist | 0.067 0.022 CID_6570 | ||
| 0.095 | 0.014 | 0.095 | Glutamate (mGluR7) antagonist | 0.071 0.041 CID_6570 | ||
| 0.102 | 0.022 | 0.102 | Estrogen-related receptor beta agonist | 0.092 0.036 CID_6570 | ||
| 0.238 | 0.158 | 0.269 | Calpain 2 inhibitor | 0.269 0.136 CID_6570 | CID_6570 | |
| 0.083 | 0.005 | 0.083 | Melatonin 2 agonist | |||
| 0.085 | 0.007 | 0.085 | Retinoid X alpha receptor agonist | 0.056 0.012 CID_6570 | ||
| 0.142 | 0.064 | 0.142 | Nav1.6 sodium channel blocker | |||
| 0.11 | 0.033 | 0.11 | Alpha 2d adrenoreceptor antagonist | |||
| 0.095 | 0.018 | 0.095 | Purinergic P2X1 antagonist | 0.074 0.028 CID_13586 0.064 0.038 CID_6570 | ||
| 0.077 | 0.001 | 0.077 | Calcineurin inhibitor | |||
| 0.082 | 0.007 | 0.082 | Retinoid X receptor agonist | 0.039 0.023 CID_13586 0.061 0.014 CID_6570 | ||
| 0.107 | 0.033 | 0.107 | Bromodomain-containing protein 2 inhibitor | |||
| 0.086 | 0.012 | 0.086 | Transcription factor RelA inhibitor | 0.063 0.046 CID_13586 0.07 0.03 CID_6570 | ||
| 0.101 | 0.028 | 0.101 | D-Ala-D-Ala ligase inhibitor | 0.084 0.056 CID_6570 | ||
| 0.118 | 0.045 | 0.118 | Carbonic anhydrase III inhibitor | 0.087 0.079 CID_6570 | ||
| 0.091 | 0.018 | 0.091 | Androgen agonist | 0.074 0.028 CID_13586 0.082 0.023 CID_6570 | ||
| 0.091 | 0.019 | 0.091 | Carbonic anhydrase VB inhibitor | 0.055 0.04 CID_6570 | ||
| 0.09 | 0.018 | 0.09 | Alpha 2 adrenoreceptor agonist | 0.085 0.021 CID_13586 | ||
| 0.081 | 0.01 | 0.081 | Prolactin release inhibitor | |||
| 0.09 | 0.019 | 0.09 | 5 Hydroxytryptamine 2A agonist | |||
| 0.078 | 0.008 | 0.096 | Factor XIIIa inhibitor | 0.096 0.006 CID_6570 | CID_6570 | |
| 0.13 | 0.059 | 0.176 | Alkylator | 0.176 0.034 CID_13586 | CID_13586 | |
| 0.082 | 0.012 | 0.082 | Nicotinic alpha3beta2 receptor antagonist | 0.056 0.032 CID_6570 | ||
| 0.133 | 0.064 | 0.16 | Antibacterial (Helicobacter pylori) | 0.16 0.039 CID_6570 | CID_6570 | |
| 0.196 | 0.127 | 0.196 | Neuropeptide Y2 antagonist | 0.175 0.171 CID_6570 | ||
| 0.111 | 0.042 | 0.111 | Antineoplastic antibiotic | 0.097 0.048 CID_13586 0.079 0.058 CID_6570 | ||
| 0.098 | 0.03 | 0.098 | Thioredoxin reductase inhibitor | 0.092 0.038 CID_13586 0.077 0.07 CID_6570 | ||
| 0.076 | 0.009 | 0.076 | Pregnane X receptor antagonist | 0.06 0.03 CID_13586 0.065 0.021 CID_6570 | ||
| 0.083 | 0.015 | 0.083 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.05 0.043 CID_13586 0.059 0.031 CID_6570 | ||
| 0.075 | 0.008 | 0.075 | Kainate receptor 2 antagonist | 0.033 0.028 CID_6570 | ||
| 0.11 | 0.043 | 0.11 | Glutamate (mGluR7) agonist | 0.101 0.058 CID_13586 | ||
| 0.081 | 0.015 | 0.081 | Sphingosine kinase 2 inhibitor | 0.068 0.023 CID_13586 0.054 0.04 CID_6570 | ||
| 0.072 | 0.006 | 0.072 | Membrane dipeptidase inhibitor | 0.04 0.026 CID_13586 0.058 0.011 CID_6570 | ||
| 0.072 | 0.006 | 0.072 | GABA uptake inhibitor | 0.044 0.02 CID_6570 | ||
| 0.11 | 0.045 | 0.11 | Interleukin 1 beta converting enzyme inhibitor | 0.101 0.056 CID_6570 | ||
| 0.106 | 0.041 | 0.106 | Histamine N-methyltransferase inhibitor | |||
| 0.109 | 0.044 | 0.109 | mTOR complex 1 inhibitor | |||
| 0.122 | 0.057 | 0.122 | Transcription factor STAT6 inhibitor | |||
| 0.117 | 0.052 | 0.145 | Alpha 2c adrenoreceptor antagonist | 0.145 0.035 CID_13586 | CID_13586 | |
| 0.202 | 0.139 | 0.229 | Lipoxygenase inhibitor | 0.229 0.115 CID_6570 | CID_6570 | |
| 0.068 | 0.005 | 0.068 | Glutamate (mGluR8) agonist | 0.038 0.025 CID_13586 0.046 0.014 CID_6570 | ||
| 0.07 | 0.008 | 0.07 | Dopamine D5 agonist | 0.045 0.022 CID_6570 | ||
| 0.144 | 0.082 | 0.144 | Diuretic | 0.115 0.111 CID_6570 | ||
| 0.072 | 0.011 | 0.072 | Potassium channel (Inward rectifier) activator | 0.064 0.015 CID_13586 0.052 0.033 CID_6570 | ||
| 0.069 | 0.009 | 0.069 | Dihydropteroate synthase inhibitor | 0.04 0.027 CID_6570 | ||
| 0.097 | 0.037 | 0.097 | mTOR complex 2 inhibitor | 0.08 0.069 CID_13586 0.078 0.076 CID_6570 | ||
| 0.067 | 0.007 | 0.067 | 5 Hydroxytryptamine 2B agonist | 0.038 0.029 CID_6570 | ||
| 0.068 | 0.007 | 0.068 | Diamine oxidase inhibitor | 0.038 0.026 CID_13586 0.055 0.012 CID_6570 | ||
| 0.124 | 0.064 | 0.124 | Beta amyloid protein antagonist | 0.105 0.084 CID_13586 | ||
| 0.095 | 0.035 | 0.095 | Caspase 7 inhibitor | 0.089 0.042 CID_13586 0.085 0.05 CID_6570 | ||
| 0.072 | 0.013 | 0.072 | Squalene epoxidase inhibitor | 0.056 0.025 CID_13586 0.053 0.029 CID_6570 | ||
| 0.07 | 0.011 | 0.07 | Factor III inhibitor | 0.063 0.015 CID_6570 | ||
| 0.064 | 0.005 | 0.064 | Uridine phosphorylase inhibitor | 0.037 0.013 CID_13586 0.043 0.01 CID_6570 | ||
| 0.076 | 0.017 | 0.076 | Acetylcholine M1 receptor agonist | |||
| 0.069 | 0.01 | 0.069 | Potassium channel (ATP-sensitive) activator | 0.061 0.015 CID_13586 0.049 0.032 CID_6570 | ||
| 0.102 | 0.044 | 0.102 | Bile acid receptor antagonist | 0.102 0.045 CID_6570 | ||
| 0.078 | 0.02 | 0.078 | Fatty acid synthase inhibitor | |||
| 0.083 | 0.025 | 0.104 | Protease 3C (Human rhinovirus) inhibitor | 0.065 0.043 CID_13586 0.104 0.014 CID_6570 | CID_6570 | |
| 0.079 | 0.021 | 0.079 | MDM2 inhibitor | 0.066 0.051 CID_13586 0.067 0.046 CID_6570 | ||
| 0.102 | 0.045 | 0.102 | Androgen antagonist | 0.081 0.064 CID_6570 | ||
| 0.105 | 0.048 | 0.108 | Alcohol dehydrogenase inhibitor | 0.108 0.044 CID_6570 | CID_6570 | |
| 0.062 | 0.005 | 0.062 | Melatonin receptor 1A agonist | 0.046 0.009 CID_6570 | ||
| 0.065 | 0.008 | 0.071 | Guanylate cyclase inhibitor | 0.071 0.004 CID_13586 0.063 0.009 CID_6570 | CID_13586 | |
| 0.076 | 0.019 | 0.076 | Calcium channel P-type blocker | 0.06 0.059 CID_6570 | ||
| 0.073 | 0.016 | 0.073 | Epithelial sodium channel blocker | |||
| 0.064 | 0.008 | 0.064 | Potassium channel Kv1.1 blocker | 0.049 0.014 CID_6570 | ||
| 0.132 | 0.076 | 0.132 | Toll-Like receptor 9 antagonist | |||
| 0.087 | 0.032 | 0.087 | Carbonic anhydrase VA inhibitor | |||
| 0.079 | 0.025 | 0.079 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.053 0.048 CID_6570 | ||
| 0.174 | 0.12 | 0.408 | Free radical scavenger | 0.408 0.027 CID_6570 | CID_6570 | |
| 0.061 | 0.007 | 0.061 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.049 0.016 CID_6570 | ||
| 0.118 | 0.063 | 0.118 | Caspase 3 inhibitor | 0.115 0.068 CID_6570 | ||
| 0.184 | 0.13 | 0.19 | Calpain inhibitor | 0.19 0.123 CID_6570 | CID_6570 | |
| 0.069 | 0.015 | 0.07 | HCV NS3/NS4A protease inhibitor | 0.057 0.023 CID_13586 0.07 0.014 CID_6570 | CID_6570 | |
| 0.063 | 0.01 | 0.063 | Alpha 1d adrenoreceptor agonist | |||
| 0.07 | 0.017 | 0.07 | Alpha-mannosidase inhibitor | 0.066 0.02 CID_13586 | ||
| 0.086 | 0.033 | 0.086 | Amidase inhibitor | 0.065 0.057 CID_6570 | ||
| 0.094 | 0.043 | 0.094 | Myeloperoxidase inhibitor | |||
| 0.084 | 0.034 | 0.084 | GABA B receptor agonist | 0.071 0.065 CID_6570 | ||
| 0.108 | 0.058 | 0.108 | Beta glucuronidase inhibitor | 0.091 0.085 CID_6570 | ||
| 0.057 | 0.008 | 0.057 | Retinoid X receptor antagonist | 0.047 0.015 CID_6570 | ||
| 0.061 | 0.012 | 0.061 | Geranyltranstransferase inhibitor | 0.04 0.038 CID_6570 | ||
| 0.056 | 0.008 | 0.067 | Heme oxygenase inhibitor | 0.067 0.005 CID_13586 0.047 0.019 CID_6570 | CID_13586 | |
| 0.115 | 0.068 | 0.115 | Interleukin 8 antagonist | |||
| 0.082 | 0.034 | 0.082 | Carbonic anhydrase V inhibitor | |||
| 0.052 | 0.005 | 0.052 | Methionyl aminopeptidase 1 inhibitor | 0.034 0.019 CID_6570 | ||
| 0.062 | 0.015 | 0.062 | Kainate receptor antagonist | 0.042 0.027 CID_6570 | ||
| 0.106 | 0.06 | 0.106 | Urease inhibitor | |||
| 0.06 | 0.014 | 0.06 | Thymidine kinase inhibitor | 0.038 0.034 CID_13586 0.041 0.028 CID_6570 | ||
| 0.061 | 0.014 | 0.061 | Glutamate (mGluR1a) antagonist | |||
| 0.064 | 0.018 | 0.064 | Adenosine deaminase inhibitor | 0.056 0.024 CID_13586 | ||
| 0.05 | 0.004 | 0.05 | Nicotinic acid receptor 2 antagonist | 0.026 0.02 CID_13586 0.037 0.006 CID_6570 | ||
| 0.089 | 0.044 | 0.089 | Carbonic anhydrase XIII inhibitor | 0.065 0.064 CID_6570 | ||
| 0.091 | 0.046 | 0.091 | Carbonic anhydrase VI inhibitor | |||
| 0.106 | 0.061 | 0.106 | MAO A inhibitor | |||
| 0.061 | 0.016 | 0.061 | CC chemokine 4 receptor antagonist | |||
| 0.107 | 0.062 | 0.114 | Mediator release inhibitor | 0.114 0.054 CID_6570 | CID_6570 | |
| 0.049 | 0.005 | 0.049 | Glutamate (mGluR1) agonist | 0.028 0.012 CID_6570 | ||
| 0.079 | 0.035 | 0.079 | Acetylcholine M5 receptor agonist | |||
| 0.105 | 0.06 | 0.105 | Gastric antisecretory | 0.104 0.061 CID_6570 | ||
| 0.076 | 0.032 | 0.076 | NMDA receptor glycine site agonist | |||
| 0.159 | 0.116 | 0.159 | Focal adhesion kinase 2 inhibitor | |||
| 0.05 | 0.007 | 0.05 | Retinoid X alpha receptor antagonist | 0.042 0.013 CID_6570 | ||
| 0.058 | 0.016 | 0.058 | Histamine H2 receptor agonist | |||
| 0.071 | 0.03 | 0.071 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.063 | 0.022 | 0.063 | Leukotriene C antagonist | 0.058 0.033 CID_13586 0.061 0.026 CID_6570 | ||
| 0.132 | 0.092 | 0.132 | Hemostatic | |||
| 0.044 | 0.004 | 0.044 | Vanilloid 2 agonist | 0.032 0.007 CID_13586 0.037 0.005 CID_6570 | ||
| 0.045 | 0.005 | 0.045 | Nicotinic alpha4beta2 receptor agonist | 0.028 0.02 CID_6570 | ||
| 0.049 | 0.009 | 0.049 | Vanilloid 3 antagonist | 0.038 0.027 CID_13586 0.037 0.029 CID_6570 | ||
| 0.058 | 0.018 | 0.058 | Mannosidase inhibitor | 0.053 0.022 CID_13586 | ||
| 0.083 | 0.044 | 0.083 | Estrogen receptor alpha antagonist | 0.073 0.061 CID_6570 | ||
| 0.085 | 0.046 | 0.085 | Macrophage migration inhibitory factor inhibitor | 0.074 0.06 CID_6570 | ||
| 0.043 | 0.004 | 0.043 | Imidazoline I1 receptor antagonist | 0.026 0.009 CID_13586 0.02 0.015 CID_6570 | ||
| 0.053 | 0.015 | 0.053 | Histamine H1 receptor agonist | |||
| 0.07 | 0.033 | 0.07 | NMDA 2C receptor antagonist | |||
| 0.06 | 0.024 | 0.06 | Immunoglobulin Fc receptor antagonist | |||
| 0.105 | 0.068 | 0.105 | Protein kinase C gamma inhibitor | |||
| 0.04 | 0.004 | 0.04 | Complement factor 1s inhibitor | 0.025 0.019 CID_13586 0.028 0.012 CID_6570 | ||
| 0.093 | 0.057 | 0.141 | Thioredoxin inhibitor | 0.141 0.02 CID_6570 | CID_6570 | |
| 0.068 | 0.032 | 0.071 | Cathepsin E inhibitor | 0.071 0.028 CID_13586 | CID_13586 | |
| 0.069 | 0.033 | 0.069 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.044 | 0.008 | 0.056 | HCV polyprotein inhibitor | 0.056 0.004 CID_13586 0.04 0.011 CID_6570 | CID_13586 | |
| 0.078 | 0.042 | 0.078 | Calcium channel L-type blocker | |||
| 0.039 | 0.003 | 0.039 | Factor XIII inhibitor | 0.02 0.015 CID_13586 0.035 0.004 CID_6570 | ||
| 0.04 | 0.005 | 0.04 | Retinoid X gamma receptor antagonist | 0.027 0.018 CID_6570 | ||
| 0.05 | 0.015 | 0.05 | Nicotinic acid receptor agonist | 0.04 0.021 CID_6570 | ||
| 0.043 | 0.008 | 0.044 | Adenosine uptake inhibitor | 0.044 0.007 CID_6570 | CID_6570 | |
| 0.04 | 0.005 | 0.048 | Prostaglandin F2 alpha agonist | 0.048 0.004 CID_13586 0.033 0.007 CID_6570 | CID_13586 | |
| 0.084 | 0.05 | 0.084 | Acetylcholine nicotinic antagonist | |||
| 0.065 | 0.031 | 0.065 | Sphingosine kinase inhibitor | 0.055 0.05 CID_13586 | ||
| 0.07 | 0.036 | 0.07 | NMDA receptor agonist | |||
| 0.036 | 0.004 | 0.036 | Neuraminidase (Influenza B) inhibitor | 0.028 0.005 CID_13586 0.029 0.005 CID_6570 | ||
| 0.082 | 0.049 | 0.082 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.08 0.051 CID_6570 | ||
| 0.058 | 0.026 | 0.058 | Antimetabolite | |||
| 0.064 | 0.032 | 0.064 | Botulinum neurotoxin type A inhibitor | |||
| 0.039 | 0.008 | 0.039 | Purinergic P2Y15 antagonist | 0.031 0.015 CID_13586 0.029 0.02 CID_6570 | ||
| 0.081 | 0.05 | 0.081 | Interferon agonist | 0.071 0.069 CID_13586 | ||
| 0.055 | 0.024 | 0.058 | Aldosterone antagonist | 0.058 0.021 CID_13586 0.049 0.031 CID_6570 | CID_13586 | |
| 0.035 | 0.004 | 0.035 | Alpha 2b adrenoreceptor agonist | 0.02 0.01 CID_6570 | ||
| 0.034 | 0.004 | 0.034 | Retinoid X beta receptor antagonist | 0.028 0.005 CID_6570 | ||
| 0.044 | 0.015 | 0.044 | CF transmembrane conductance regulator antagonist | |||
| 0.055 | 0.026 | 0.055 | CD45 antagonist | |||
| 0.068 | 0.038 | 0.068 | Interferon inducer | 0.061 0.051 CID_13586 | ||
| 0.036 | 0.007 | 0.036 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.027 0.016 CID_13586 0.028 0.015 CID_6570 | ||
| 0.06 | 0.031 | 0.062 | Glucosylceramidase inhibitor | 0.062 0.029 CID_13586 | CID_13586 | |
| 0.053 | 0.024 | 0.053 | Thymidylate synthase inhibitor | |||
| 0.048 | 0.019 | 0.048 | Progesterone antagonist | |||
| 0.064 | 0.035 | 0.064 | Glutamate (mGluR1) antagonist | |||
| 0.052 | 0.024 | 0.052 | Cytokine production stimulant | 0.049 0.031 CID_13586 0.05 0.03 CID_6570 | ||
| 0.129 | 0.101 | 0.129 | Neuropeptide Y1 antagonist | |||
| 0.075 | 0.047 | 0.075 | Potassium channel (Tandem pore domain) blocker | |||
| 0.044 | 0.017 | 0.044 | Phosphoglycerate kinase inhibitor | 0.038 0.021 CID_13586 0.033 0.027 CID_6570 | ||
| 0.077 | 0.049 | 0.077 | Acetylcholine M4 receptor antagonist | |||
| 0.031 | 0.004 | 0.031 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.024 0.008 CID_6570 | ||
| 0.048 | 0.021 | 0.048 | Nerve growth factor antagonist | |||
| 0.058 | 0.031 | 0.058 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.04 | 0.013 | 0.04 | ATP citrate lysase inhibitor | 0.032 0.022 CID_6570 | ||
| 0.039 | 0.013 | 0.039 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.026 0.021 CID_13586 | ||
| 0.11 | 0.084 | 0.11 | MAP kinase kinase inhibitor | |||
| 0.034 | 0.008 | 0.034 | Lysophosphatidic acid receptor 1 agonist | 0.026 0.015 CID_6570 | ||
| 0.03 | 0.005 | 0.03 | Alpha 2c adrenoreceptor agonist | 0.017 0.016 CID_6570 | ||
| 0.061 | 0.035 | 0.061 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.064 | 0.039 | 0.069 | Aromatase inhibitor | 0.069 0.035 CID_13586 0.066 0.037 CID_6570 | CID_13586 | |
| 0.048 | 0.023 | 0.048 | Glutamate (mGluR4) antagonist | |||
| 0.083 | 0.058 | 0.083 | Histamine H2 receptor antagonist | |||
| 0.051 | 0.026 | 0.051 | Oleamide hydrolase inhibitor | 0.045 0.032 CID_6570 | ||
| 0.091 | 0.066 | 0.091 | Potassium channel (Voltage-sensitive) activator | |||
| 0.042 | 0.018 | 0.042 | Integrin alpha1beta1 antagonist | |||
| 0.037 | 0.013 | 0.037 | Glutamate (mGluR3) agonist | |||
| 0.036 | 0.013 | 0.036 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.033 | 0.009 | 0.033 | Thymidine phosphorylase inhibitor | |||
| 0.044 | 0.021 | 0.07 | 5-Alpha-reductase inhibitor | 0.07 0.014 CID_6570 | CID_6570 | |
| 0.041 | 0.019 | 0.041 | Integrin alpha2 antagonist | |||
| 0.074 | 0.052 | 0.074 | Phosphodiesterase VI inhibitor | |||
| 0.06 | 0.038 | 0.06 | Xanthine dehydrogenase inhibitor | |||
| 0.072 | 0.051 | 0.072 | Cathepsin G inhibitor | |||
| 0.06 | 0.039 | 0.06 | Cyclin A1 inhibitor | |||
| 0.042 | 0.02 | 0.042 | Leukotriene C4 antagonist | 0.038 0.03 CID_13586 0.04 0.024 CID_6570 | ||
| 0.026 | 0.005 | 0.026 | Nicotinic alpha4 receptor agonist | |||
| 0.026 | 0.005 | 0.026 | Carbonic anhydrase VIII inhibitor | 0.016 0.013 CID_6570 | ||
| 0.026 | 0.005 | 0.026 | Carbonic anhydrase X inhibitor | 0.016 0.013 CID_6570 | ||
| 0.047 | 0.026 | 0.047 | Oxytocin agonist | |||
| 0.03 | 0.01 | 0.03 | Retinoid X gamma receptor agonist | |||
| 0.053 | 0.032 | 0.053 | Prolyl endopeptidase inhibitor | |||
| 0.029 | 0.009 | 0.029 | Glutamate (mGluR1a) agonist | |||
| 0.048 | 0.028 | 0.048 | Purinergic P2X4 antagonist | |||
| 0.055 | 0.035 | 0.055 | Leukotriene B4 antagonist | 0.05 0.044 CID_6570 | ||
| 0.042 | 0.022 | 0.042 | TRPM8 blocker | |||
| 0.056 | 0.036 | 0.056 | Ribonucleoside-diphosphate reductase inhibitor | 0.052 0.039 CID_6570 | ||
| 0.03 | 0.01 | 0.03 | Kainate receptor 1 antagonist | |||
| 0.065 | 0.045 | 0.065 | Aryl hydrocarbon receptor antagonist | |||
| 0.054 | 0.035 | 0.055 | Heparanase inhibitor | 0.055 0.033 CID_13586 | CID_13586 | |
| 0.045 | 0.026 | 0.045 | Dihydrofolate reductase inhibitor | |||
| 0.126 | 0.107 | 0.133 | Phospholipase A2 inhibitor | 0.133 0.096 CID_6570 | CID_6570 | |
| 0.028 | 0.009 | 0.028 | Retinoid X beta receptor agonist | |||
| 0.031 | 0.012 | 0.031 | Integrin alpha2beta1 antagonist | |||
| 0.057 | 0.038 | 0.057 | Ribonucleotide reductase inhibitor | 0.051 0.041 CID_6570 | ||
| 0.066 | 0.047 | 0.066 | 5 Hydroxytryptamine 3A antagonist | |||
| 0.186 | 0.167 | 0.186 | Prostaglandin dehydrogenase inhibitor | |||
| 0.03 | 0.012 | 0.03 | Hedgehog signaling activator | |||
| 0.08 | 0.061 | 0.08 | Ca(v)3.1 blocker | |||
| 0.064 | 0.046 | 0.064 | Beta 3 adrenoreceptor antagonist | |||
| 0.031 | 0.013 | 0.031 | Estrogen-related receptor gamma antagonist | |||
| 0.023 | 0.005 | 0.023 | NMDA receptor phencyclidine site antagonist | 0.016 0.01 CID_13586 | ||
| 0.072 | 0.055 | 0.072 | Adenosine A3 receptor antagonist | |||
| 0.036 | 0.018 | 0.036 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.032 0.022 CID_6570 | ||
| 0.035 | 0.017 | 0.035 | Acetylcholine M4 receptor agonist | |||
| 0.046 | 0.029 | 0.046 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.023 | 0.006 | 0.023 | CXC chemokine 5 receptor antagonist | |||
| 0.022 | 0.005 | 0.022 | Lysophosphatidic acid receptor 3 agonist | 0.02 0.005 CID_13586 0.014 0.009 CID_6570 | ||
| 0.027 | 0.01 | 0.027 | 5 Hydroxytryptamine 4 agonist | |||
| 0.03 | 0.013 | 0.031 | Sodium/glucose cotransporter 2 inhibitor | 0.031 0.012 CID_13586 | CID_13586 | |
| 0.068 | 0.051 | 0.068 | Protein kinase C beta inhibitor | |||
| 0.072 | 0.055 | 0.09 | Alpha 2a adrenoreceptor antagonist | 0.09 0.042 CID_13586 | CID_13586 | |
| 0.061 | 0.044 | 0.061 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.144 | 0.127 | 0.144 | MAP kinase kinase 2 inhibitor | |||
| 0.026 | 0.009 | 0.027 | Isoleucine-tRNA ligase inhibitor | 0.027 0.008 CID_13586 | CID_13586 | |
| 0.022 | 0.006 | 0.022 | Methylmalonyl-CoA mutase inhibitor | 0.02 0.01 CID_13586 0.019 0.011 CID_6570 | ||
| 0.045 | 0.029 | 0.045 | Glutamate (mGluR group III) antagonist | |||
| 0.059 | 0.043 | 0.059 | Acetylcholine M5 receptor antagonist | |||
| 0.022 | 0.006 | 0.022 | Telomerase stimulant | 0.02 0.008 CID_13586 0.018 0.011 CID_6570 | ||
| 0.113 | 0.097 | 0.113 | Toll-Like receptor antagonist | |||
| 0.038 | 0.023 | 0.04 | Inosine monophosphate dehydrogenase inhibitor | 0.04 0.021 CID_13586 | CID_13586 | |
| 0.059 | 0.044 | 0.059 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.068 | 0.054 | 0.068 | Benzodiazepine agonist | |||
| 0.125 | 0.11 | 0.125 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.064 | 0.05 | 0.064 | Neuronal nicotinic receptor antagonist | |||
| 0.044 | 0.03 | 0.044 | AICAR transformylase inhibitor | |||
| 0.057 | 0.043 | 0.057 | Carbonic anhydrase stimulant | |||
| 0.034 | 0.021 | 0.034 | Protein kinase (CK2) beta inhibitor | |||
| 0.019 | 0.006 | 0.019 | Thromboxane A2 agonist | |||
| 0.017 | 0.005 | 0.017 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.062 | 0.05 | 0.062 | Fibroblast growth factor 2 antagonist | |||
| 0.021 | 0.009 | 0.024 | Antibiotic Anthracycline-like | 0.024 0.005 CID_13586 0.021 0.01 CID_6570 | CID_13586 | |
| 0.061 | 0.049 | 0.061 | Dopamine D1 antagonist | |||
| 0.101 | 0.09 | 0.101 | MAO inhibitor | 0.098 0.092 CID_6570 | ||
| 0.032 | 0.021 | 0.032 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.079 | 0.068 | 0.106 | Alpha 2 adrenoreceptor antagonist | 0.106 0.044 CID_13586 | CID_13586 | |
| 0.049 | 0.038 | 0.049 | CC chemokine 5 receptor antagonist | |||
| 0.025 | 0.014 | 0.025 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.036 | 0.026 | 0.036 | Arginase inhibitor | |||
| 0.038 | 0.028 | 0.038 | Vascular adhesion protein 1 inhibitor | |||
| 0.026 | 0.016 | 0.026 | Sodium/glucose cotransporter inhibitor | 0.026 0.016 CID_13586 | ||
| 0.031 | 0.022 | 0.031 | Potassium channel small-conductance Ca-activated activator | |||
| 0.054 | 0.044 | 0.054 | Dopamine uptake inhibitor | |||
| 0.126 | 0.117 | 0.126 | Heat shock protein 90 alpha antagonist | |||
| 0.039 | 0.029 | 0.039 | AMPA 4 receptor antagonist | |||
| 0.027 | 0.018 | 0.027 | Lysine carboxypeptidase inhibitor | |||
| 0.033 | 0.024 | 0.033 | Melatonin 1 agonist | |||
| 0.013 | 0.005 | 0.013 | Imidazoline I2 receptor antagonist | 0.01 0.009 CID_13586 | ||
| 0.014 | 0.006 | 0.014 | Glutamate (mGluR6) agonist | |||
| 0.055 | 0.047 | 0.055 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.026 | 0.018 | 0.026 | Acid ceramidase inhibitor | |||
| 0.045 | 0.038 | 0.045 | Cholesterol esterase inhibitor | |||
| 0.108 | 0.101 | 0.124 | DNA repair enzyme inhibitor | 0.124 0.065 CID_13586 | CID_13586 | |
| 0.016 | 0.009 | 0.017 | Purinergic P2Y1 agonist | 0.017 0.008 CID_13586 | CID_13586 | |
| 0.073 | 0.066 | 0.073 | Acetylcholine nicotinic agonist | |||
| 0.081 | 0.074 | 0.081 | Fibroblast growth factor 1 antagonist | |||
| 0.047 | 0.041 | 0.058 | 5 Hydroxytryptamine 2 agonist | 0.058 0.029 CID_13586 | CID_13586 | |
| 0.043 | 0.037 | 0.044 | Carbonic anhydrase VII inhibitor | 0.044 0.036 CID_6570 | CID_6570 | |
| 0.028 | 0.022 | 0.028 | MAP3K8 inhibitor | |||
| 0.029 | 0.023 | 0.029 | Prostaglandin agonist | |||
| 0.217 | 0.212 | 0.237 | Transcription factor inhibitor | 0.237 0.196 CID_6570 | CID_6570 | |
| 0.017 | 0.011 | 0.018 | Vitamin D receptor agonist | 0.018 0.008 CID_6570 | CID_6570 | |
| 0.029 | 0.023 | 0.03 | Peptide deformylase inhibitor | 0.03 0.022 CID_6570 | CID_6570 | |
| 0.013 | 0.007 | 0.013 | Melatonin 2 antagonist | |||
| 0.042 | 0.037 | 0.042 | CDK7/cyclin H inhibitor | |||
| 0.046 | 0.041 | 0.046 | NMDA 2A receptor antagonist | |||
| 0.04 | 0.035 | 0.04 | NMDA receptor subunit 3B antagonist | |||
| 0.013 | 0.008 | 0.013 | Carbonic anhydrase XI inhibitor | |||
| 0.065 | 0.06 | 0.065 | Secretase beta inhibitor | |||
| 0.03 | 0.026 | 0.03 | Melatonin agonist | |||
| 0.08 | 0.076 | 0.08 | Potassium channel activator | |||
| 0.085 | 0.081 | 0.085 | MAP kinase kinase kinase inhibitor | |||
| 0.017 | 0.013 | 0.017 | Alpha 2a adrenoreceptor agonist | |||
| 0.022 | 0.018 | 0.022 | Dopamine autoreceptor agonist | |||
| 0.039 | 0.035 | 0.045 | Leukocyte elastase inhibitor | 0.045 0.028 CID_6570 | CID_6570 | |
| 0.013 | 0.01 | 0.013 | Antibiotic Macrolide-like | |||
| 0.054 | 0.051 | 0.054 | Opioid delta receptor antagonist | |||
| 0.059 | 0.057 | 0.059 | Beta adrenoreceptor antagonist | |||
| 0.037 | 0.034 | 0.037 | Liver X receptor alpha agonist | |||
| 0.007 | 0.005 | 0.007 | DNA topoisomerase III inhibitor | |||
| 0.02 | 0.017 | 0.02 | Lysophosphatidic acid 1 receptor antagonist | |||
| 0.036 | 0.034 | 0.036 | Histone deacetylase 9 inhibitor | |||
| 0.033 | 0.031 | 0.033 | Glutamate (mGluR3) antagonist | |||
| 0.105 | 0.103 | 0.105 | Nav1.2 sodium channel blocker | |||
| 0.057 | 0.055 | 0.057 | Leukotriene antagonist | |||
| 0.032 | 0.03 | 0.032 | 5 Hydroxytryptamine 3B antagonist | |||
| 0.021 | 0.02 | 0.021 | ICAM 1 antagonist | |||
| 0.009 | 0.007 | 0.009 | Progesterone receptor A antagonist | |||
| 0.016 | 0.015 | 0.016 | Nicotinic acid receptor 1 antagonist | |||
| 0.058 | 0.057 | 0.058 | Histone deacetylase SIRT3 inhibitor | |||
| 0.02 | 0.019 | 0.077 | Vitamin D receptor antagonist | 0.022 0.016 CID_13586 0.077 0.003 CID_6570 | CID_6570 | |
| 0.038 | 0.037 | 0.038 | Sphingosine kinase 1 inhibitor | |||
| 0.054 | 0.053 | 0.054 | Heat shock protein 90 beta antagonist | |||
| 0.028 | 0.027 | 0.028 | Epoxide hydrolase 1 inhibitor | |||
| 0.015 | 0.017 | 0.018 | Cyclin T1 inhibitor | 0.018 0.012 CID_13586 | CID_13586 | |
| 0.01 | 0.015 | 0.013 | Human herpes virus 5 capsid protein P40 inhibitor | 0.013 0.008 CID_6570 | CID_6570 | |
| 0.031 | 0.04 | 0.051 | Calcium-independent phospholipase A2 inhibitor | 0.051 0.004 CID_6570 | CID_6570 | |
| 0.04 | 0.065 | 0.065 | HIV-1 integrase (Strand Transfer) inhibitor | 0.065 0.039 CID_6570 | CID_6570 | |
| 0.024 | 0.055 | 0.049 | Estrogen-related receptor beta antagonist | 0.049 0.006 CID_13586 | CID_13586 | |
| 0.035 | 0.078 | 0.056 | Cathepsin L inhibitor | 0.056 0.044 CID_6570 | CID_6570 | |
| 0.013 | 0.064 | 0.145 | Glucocorticoid antagonist | 0.145 0.004 CID_13586 | CID_13586 | |
| 0.095 | 0.152 | 0.144 | Neurotrophic factor | 0.144 0.064 CID_6570 | CID_6570 | |
| 0.081 | 0.139 | 0.161 | Electron transport complex I inhibitor | 0.161 0.016 CID_6570 | CID_6570 | |
| 0.035 | 0.097 | 0.053 | Glucose-6-phosphate translocase inhibitor | 0.053 0.033 CID_6570 | CID_6570 | |
| 0.049 | 0.151 | 0.108 | Chymotrypsin inhibitor | 0.108 0.031 CID_6570 | CID_6570 | |
| 0.046 | 0.189 | 0.285 | Falcipain 2 inhibitor | 0.285 0.005 CID_6570 | CID_6570 | |
| 0.047 | 0.196 | 0.286 | Falcipain inhibitor | 0.286 0.005 CID_6570 | CID_6570 | |
| 0.042 | 0.212 | 0.104 | ATPase (Vacuolar H+) inhibitor | 0.104 0.035 CID_13586 | CID_13586 | |
| 0.046 | 0.27 | 0.418 | Interleukin 1b antagonist | 0.418 0.005 CID_6570 | CID_6570 | |
| 0.009 | 0.302 | 0.031 | Cyclophilin A inhibitor | 0.031 0.021 CID_6570 | CID_6570 | |
| 0.053 | 0.363 | 0.187 | Platelet adhesion inhibitor | 0.187 0.078 CID_6570 | CID_6570 | |
| 0.054 | 0.379 | 0.151 | Interleukin 6 antagonist | 0.151 0.087 CID_13586 | CID_13586 | |
| 0.02 | 0.414 | 0.114 | Acetylcholine M3 receptor agonist | 0.114 0.038 CID_13586 | CID_13586 | |
| 0.045 | 0.441 | 0.323 | Tumour necrosis factor alpha release inhibitor | 0.323 0.045 CID_13586 | CID_13586 | |
| 0.075 | 0.529 | 0.268 | Apoptosis antagonist | 0.268 0.11 CID_6570 | CID_6570 | |
| 0.018 | 0.516 | 0.091 | Uric acid excretion stimulant | 0.091 0.063 CID_6570 | CID_6570 | |
| 0.014 | 0.541 | 0.084 | Protease inhibitor | 0.084 0.081 CID_6570 | CID_6570 | |
| 0.005 | 0.594 | 0.052 | Mineralocorticoid receptor antagonist | 0.052 0.028 CID_13586 | CID_13586 | |
| 0.018 | 0.666 | 0.456 | Interleukin 1 antagonist | 0.456 0.005 CID_6570 | CID_6570 | |
| 0.025 | 0.756 | 0.377 | Hypoglycemic | 0.377 0.032 CID_13586 | CID_13586 | |
| 0.001 | 0.786 | 0.015 | KiSS-1 receptor antagonist | 0.015 0.014 CID_6570 | CID_6570 | |
| 0.005 | 0.89 | 0.266 | Interleukin antagonist | 0.266 0.056 CID_6570 | CID_6570 | |
| 0.004 | 0.918 | 0.15 | EphA2 antagonist | 0.15 0.03 CID_13586 | CID_13586 | |
| 0.005 | 0.94 | 0.104 | Human rhinovirus A protease inhibitor | 0.104 0.015 CID_6570 | CID_6570 | |
| 0.005 | 0.943 | 0.085 | Transcription factor AP-1 inhibitor | 0.085 0.018 CID_6570 | CID_6570 | |
| 0.019 | 0.978 | 0.145 | Lipocortins synthesis antagonist | 0.145 0.113 CID_6570 | CID_6570 | |
| 0.01 | 0.997 | 0.261 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.261 0.053 CID_13586 | CID_13586 | |
| 0.002 | 0.997 | 0.108 | Phosphodiesterase VIII inhibitor | 0.108 0.01 CID_13586 | CID_13586 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |